醋酸甲羟孕酮治疗乳腺癌 - Suppr

Treatment of breast cancer with medroxyprogesterone acetate.

作者信息

Muggia F M, Cassieth P A, Ochoa M, Flatow F A, Gellhorn A, Hyman G A

出版信息

Ann Intern Med. 1968 Feb;68(2):328-37. doi: 10.7326/0003-4819-68-2-328.

DOI:10.7326/0003-4819-68-2-328

PMID:4306126

Abstract

摘要

相似文献

Treatment of breast cancer with medroxyprogesterone acetate.

Ann Intern Med. 1968 Feb;68(2):328-37. doi: 10.7326/0003-4819-68-2-328.

Treatment of seizures with medroxyprogesterone acetate: preliminary report.

Neurology. 1984 Sep;34(9):1255-8. doi: 10.1212/wnl.34.9.1255.

Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.

Steroids. 1975 Sep;26(3):373-86. doi: 10.1016/0039-128x(75)90082-3.

Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.

Acta Obstet Gynecol Scand. 1979;58(1):95-9. doi: 10.3109/00016347909154923.

The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.

J Clin Endocrinol Metab. 1976 Dec;43(6):1226-33. doi: 10.1210/jcem-43-6-1226.

High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation.

Tumori. 1978 Apr 30;64(2):143-9. doi: 10.1177/030089167806400204.

Pharmacokinetic study of different doses of Depo Provera.

Contraception. 1980 Nov;22(5):527-36. doi: 10.1016/0010-7824(80)90105-5.

Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.

Acta Endocrinol (Copenh). 1982 Mar;99(3):339-43. doi: 10.1530/acta.0.0990339.

High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A review.

Tumori. 1979 Oct 31;65(5):563-85. doi: 10.1177/030089167906500507.

Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.

Contraception. 1993 May;47(5):427-44. doi: 10.1016/0010-7824(93)90095-o.

引用本文的文献

The Androgen Receptor in Breast Cancer.

Front Endocrinol (Lausanne). 2018 Aug 28;9:492. doi: 10.3389/fendo.2018.00492. eCollection 2018.

Exogenous reproductive hormone use in breast cancer survivors and previvors.

Nat Rev Clin Oncol. 2018 Apr;15(4):249-261. doi: 10.1038/nrclinonc.2017.207. Epub 2018 Jan 23.

Androgen Receptor: A Complex Therapeutic Target for Breast Cancer.

Cancers (Basel). 2016 Dec 2;8(12):108. doi: 10.3390/cancers8120108.

Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes.

Cancer Chemother Pharmacol. 1980;4(4):267-9. doi: 10.1007/BF00255272.

Long acting contraceptives. Present status.

Drugs. 1983 Jun;25(6):570-609. doi: 10.2165/00003495-198325060-00003.

Hormonal management of breast cancer.

Br Med J. 1969 Jul 19;3(5663):179. doi: 10.1136/bmj.3.5663.179-a.

Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Calif Med. 1969 Jan;110(1):43-60.

Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer.

Breast Cancer Res Treat. 1985;5(3):321-6. doi: 10.1007/BF01806027.

High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy.

Cancer Chemother Pharmacol. 1979;2(3):175-80. doi: 10.1007/BF00258291.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment of breast cancer with medroxyprogesterone acetate.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Treatment of breast cancer with medroxyprogesterone acetate.

作者信息

出版信息

相似文献

引用本文的文献